143 related articles for article (PubMed ID: 20647341)
21. MicroRNA-215 is a potential prognostic marker for cervical cancer.
Liang H; Li Y; Luo RY; Shen FJ
J Huazhong Univ Sci Technolog Med Sci; 2014 Apr; 34(2):207-212. PubMed ID: 24710934
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.
Liu F; You X; Chi X; Wang T; Ye L; Niu J; Zhang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):128-34. PubMed ID: 24434140
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
24. MiR-215 modulates gastric cancer cell proliferation by targeting RB1.
Deng Y; Huang Z; Xu Y; Jin J; Zhuo W; Zhang C; Zhang X; Shen M; Yan X; Wang L; Wang X; Kang Y; Si J; Zhou T
Cancer Lett; 2014 Jan; 342(1):27-35. PubMed ID: 23981575
[TBL] [Abstract][Full Text] [Related]
25. Functional implications of microRNA-215 in TGF-β1-induced phenotypic transition of mesangial cells by targeting CTNNBIP1.
Mu J; Pang Q; Guo YH; Chen JG; Zeng W; Huang YJ; Zhang J; Feng B
PLoS One; 2013; 8(3):e58622. PubMed ID: 23554908
[TBL] [Abstract][Full Text] [Related]
26. A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
Maurel M; Jalvy S; Ladeiro Y; Combe C; Vachet L; Sagliocco F; Bioulac-Sage P; Pitard V; Jacquemin-Sablon H; Zucman-Rossi J; Laloo B; Grosset CF
Hepatology; 2013 Jan; 57(1):195-204. PubMed ID: 22865282
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of miR-215 in colon cancer.
Karaayvaz M; Pal T; Song B; Zhang C; Georgakopoulos P; Mehmood S; Burke S; Shroyer K; Ju J
Clin Colorectal Cancer; 2011 Dec; 10(4):340-7. PubMed ID: 21752725
[TBL] [Abstract][Full Text] [Related]
28. miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.
Li T; Gao F; Zhang XP
Oncol Rep; 2015 Feb; 33(2):607-14. PubMed ID: 25482885
[TBL] [Abstract][Full Text] [Related]
29. Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids.
Sabeti Aghabozorgi A; Moradi Sarabi M; Jafarzadeh-Esfehani R; Koochakkhani S; Hassanzadeh M; Kavousipour S; Eftekhar E
World J Gastrointest Oncol; 2020 Sep; 12(9):942-956. PubMed ID: 33005290
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
[TBL] [Abstract][Full Text] [Related]
31. An insight into thymidylate synthase inhibitor as anticancer agents: an explicative review.
Sen A; Karati D
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38446215
[TBL] [Abstract][Full Text] [Related]
32. MiR-548c-3p through suppressing
Khalili E; Afgar A; Rajabpour A; Aghaee-Bakhtiari SH; Jamialahmadi K; Teimoori-Toolabi L
Heliyon; 2023 Nov; 9(11):e21775. PubMed ID: 38045156
[TBL] [Abstract][Full Text] [Related]
33. Association of Thymidylate Synthase (
Kim JO; Ryu CS; Lee JY; Ko EJ; Ha YH; Sung JH; Hwang TS; Kim IJ; Kim NK
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628769
[TBL] [Abstract][Full Text] [Related]
34. Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy.
Mafi A; Rezaee M; Hedayati N; Hogan SD; Reiter RJ; Aarabi MH; Asemi Z
Cell Commun Signal; 2023 Feb; 21(1):33. PubMed ID: 36759799
[TBL] [Abstract][Full Text] [Related]
35. Improving the prediction for the response to radiotherapy of clinical tumor samples by using combinatorial model of MicroRNA expression.
Tang C; Qi J; Wu Y; Luo L; Wang Y; Wu Y; Shi X
Front Genet; 2022; 13():1069112. PubMed ID: 36482894
[No Abstract] [Full Text] [Related]
36. A Systematic Review of Clinical Validated and Potential miRNA Markers Related to the Efficacy of Fluoropyrimidine Drugs.
Sun X; Chen J; Chen X; Gao Q; Chen W; Zou X; Zhang F; Gao S; Qiu S; Yue X; Yao H; Liu X; Li M
Dis Markers; 2022; 2022():1360954. PubMed ID: 36051356
[TBL] [Abstract][Full Text] [Related]
37. Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics.
Yuen JG; Fesler A; Hwang GR; Chen LB; Ju J
Mol Ther; 2022 Nov; 30(11):3450-3461. PubMed ID: 35933584
[TBL] [Abstract][Full Text] [Related]
38. MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.
Matuszyk J
Mol Med; 2022 Aug; 28(1):89. PubMed ID: 35922756
[TBL] [Abstract][Full Text] [Related]
39. Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer.
Merz V; Mangiameli D; Zecchetto C; Quinzii A; Pietrobono S; Messina C; Casalino S; Gaule M; Pesoni C; Vitale P; Trentin C; Frisinghelli M; Caffo O; Melisi D
Front Surg; 2022; 9():866173. PubMed ID: 35599791
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA as a Potential Therapeutic Molecule in Cancer.
Szczepanek J; Skorupa M; Tretyn A
Cells; 2022 Mar; 11(6):. PubMed ID: 35326459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
